NCICBR26_2B | R Documentation |
Kaplan-Meier digitized data from NCICBR26, figure 2B (PMID 25439692). A reported sample size of 720 for a primary endpoint of OS in lung cancer.
NCICBR26_2B
A data frame of 720 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (dacomitinib, placebo) | |
Ellis PM, Shepherd FA, Millward M, et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet Oncol 2014; 15: 1379–88.
summary(NCICBR26_2B)
kmplot(NCICBR26_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.